FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes

PARIS and THE WOODLANDS, TX– January 17, 2019– The Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) today voted eight to eight on the question of whether the overall benefits of...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news